Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Secretome Analysis of Time- and Passage-Dependent of Wharton's Jelly Mesenchymal Stem Cells Using Quantitative Proteomic

ABSTRACT: This dataset contains proteins from the secretomes (Conditioned Media) of Wharton's Jelly Mesenchymal Stem Cells (WJMSC) harvested at different time points (24, 48, and 72 hours) and cell passages (Passage 3, Passage 5, and Passage 10). The samples used were taken from 2 donors. The research aims to understand how the composition of the secretome changes over time and with different cell passages. Advanced proteomic techniques are used to analyze the bioactive molecules secreted by WJMSCs, highlighting the impact of time and cell passage number on the therapeutic potential of these cells. This research seeks to enhance the clinical efficiency of WJMSCs for regenerative medicine applications by revealing the dynamic nature of their secretome.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Wan Safwani Wan Kamarul Zaman

PROVIDER: MSV000095902 | MassIVE |

SECONDARY ACCESSION(S): PXD056000

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Evaluation Of Wharton's Jelly Mesenchymal Stem Cells Secretome Profiling Derived In Time And Passage Dependent Manner

Project description:The data provided is from LCMS run of Wharton's Jelly Mesenchymal Stem Cells (WJMSC) derived secretomes. The samples consist of secretomes harvested at different time points (24, 48, and 72 hours) and passage numbers (P3, P5, and P10). The samples used were taken from 3 donors, with 3 technical runs for each sample. Thus, a total of 81 samples of data were collected. The research aims to understand how the composition of the secretome changes over time and with different cell passages. Advanced proteomic techniques are used to analyze the bioactive molecules secreted by WJMSCs, highlighting the impact of time and cell passage number on the therapeutic potential of these cells. This research seeks to enhance the clinical efficiency of WJMSCs for regenerative medicine applications by revealing the dynamic nature of their secretome.

2024-11-09 | MSV000096363 | MassIVE

Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of Mesenchymal Stromal Cell (MSC)-derived soluble proteins and Extracellular Vesicles (EVs)

Project description:Mesenchymal stromal cells (MSCs) are characterized by a regulatory phenotype and respond promptly to the environmental signals modulating their secretory activity. An appropriate preconditioning may induce MSCs to release secretomes with an enhanced regenerative potential. However, it fails to take into account that secretomes are composed by both soluble factors and extracellular vesicles (EVs), whose functions could be altered differently by the preconditioning approach. Here we demonstrate that the MSC secretome is strongly modulated by the simultaneous stimulation with hypoxia and pro-inflammatory cytokines, used to mimic the harsh environment present at the site of injury. The cargo content (in terms of miRNAs) of the corresponding EV fractions was less sensitive to the influence of the external stimuli.

2021-03-01 | GSE161474 | GEO

Passage dependent gene expression in normal human dermal fibroblasts

Project description:Human umbilical vein endothelial cells (HUVECs) formed capillary structures when co-cultured with normal human dermal fibroblasts (NHDFs). HUVEC competence and NHDF supportiveness of cord formation were found to be highly cell-passage dependent with the early passage cells forming more angiogenic cord structures. We thus profiled gene expression in NHDFs with different passages to understand the molecular mechanisms underlying the in vitro angiogenesis control. Keywords: Time course

2008-05-13 | GSE11418 | GEO

Effect of therapy-induced secretomes on the transcriptome of ovarian cancer cells

Project description:Exogenous signals from drug-stressed cancer cells promote acquisition of a more aggressive phenotype of neighboring tumor cells. Recently, we examined how cancer cell secretome changes in response to chemotherapy. We showed that tumor therapy-induced secretomes significantly increased resistance of cancer cells to subsequent cisplatin treatment but we did not observed the same phenomenon on normal fibroblasts. To elucidate how therapy-induced secretomes affect the transcriptomic profiles of recipient tumor cells, we incubated SKOV3 cells for 3 days with secretomes from control or dying cancer cells. The same conditions were used for normal fibroblasts. Enrichment analysis of differentially expressed genes in SKOV3 cells incubated with therapy-induced secretomes identified prominent up-regulation of genes involved in coordination of mitotic processes, G2/M transition checkpoints and DNA repair. These findings demonstrate that under stress condition cancer but not normal cells can secrete signaling molecules into the exracellular space and contribute to the emergence of tumor chemoresistance during short time period.

2024-04-24 | GSE241910 | GEO

Culture effects on rheumatoid arthrits synovial fibroblasts

Project description:Comparison between early passage to later passages of rheumatoid arthritis synovial fibroblast (RASF) populations using two different AtlasTM Human Arrays Gene expression changes during culture with increasing number of changes at higher passages depending on individual expression pattern of the respective cell populations

2010-04-20 | GSE21385 | GEO

Effect of cell passage number on gene expression in NR8383 macrophages

Project description:Continuous cell lines are important research tools in biology and medicine. However, literature demonstrates that over-subculturing changes cell lines properties over time. In addition, cultured cells adapt to stress and confusion by evolution - both genotypic and phenotypic. The aim of this study is to identify differentially expressed genes and key biological pathways at high-passage cells compared to lower-passage cells. To do that, we performed microarray analyses on NR8383 macrophages at 20 and 200 passages numbers. This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 686098

2021-07-23 | GSE117487 | GEO

WU-BC 3, 4, and 5 PAM50 Subtypes with Passage and Gene Expression Comparison Between Xenografts and Primary Tumors

Project description:Whole genome expression studies were performed on Xenograft panels with multiple passages from 3 different patient tumors. We assessed the global gene expression concordance from passages to passage and from passage to primary tumor when available and performed PAM50 subtype classification. These results were examined within the context of 40 PAM50 prototype experiments.

2012-10-10 | GSE28860 | GEO

E-PROT-110

Project description:Secretome analysis of colorectal cancer cell linesSW620, KM12SM, and KM12L4 cell lines

2023-11-08 | E-PROT-110 | ExpressionAtlas

Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic and 1 degenerative intervertebral discs: A proteomic analysis

Project description:Mesenchymal stromal cells (MSCs) have been introduced as promising cell source for regenerative medicine. Besides their multilineage differentiation capacity, MSCs release a wide spectrum of bioactive factors. This secretome holds immunomodulatory and regenerative capacities. In intervertebral disc (IVD) cells, application of MSC secretome has been shown to decrease the apoptosis rate, induce proliferation and promote production of extracellular matrix (ECM). For clinical translation of secretome-based treatment, characterization of the secretome composition is needed to better understand the induced biological processes and identify potentially effective secretomes. Methods: This study aimed to investigate the proteome released by bone marrow derived MSCs following exposure to a healthy, traumatic, or degenerative human IVD environment by mass spectroscopy and quantitative immunoassay analyses. Exposure of MSCs to the proinflammatory stimulus interleukin 1β (IL-1b) was used as control.

2021-09-09 | PXD021281 | Pride

Evaluation of secretomes derived from human dermal and adipose tissue mesenchymal stem/stromal cells for skin wound healing: Not as effective as cells

Project description:Although the paracrine effects of mesenchymal stem/stromal cells (MSCs) have been recognized as crucial mediators of their regenerative effects on tissue repair, the potential of MSC secretomes as effective substitutes for cellular therapies remains underexplored. In this study, we compared MSCs from the human dermis (DSCs) and adipose tissue (ASCs) with their secretomes regarding their efficacy for skin wound healing using a translationally-relevant murine model. Proteomic analysis revealed that while there was a substantial overlap in protein composition between DSC and ASC secretomes, specific proteins associated with wound healing and angiogenesis were differentially expressed. Despite a similar angiogenic potential in vivo, DSC- and ASC-secretomes were found to be less effective than cells in accelerating wound closure and promoting tissue remodeling. Overall, secretome-treated groups showed intermediary results between cells and control (empty scaffold) treated groups. These findings highlight that although secretomes possess therapeutic potential, their efficacy might be limited compared to cellular therapies. This study contributes to the growing understanding of MSC secretomes, emphasizes the need for further protocol optimization, and offers insights into their potential applications in regenerative medicine.

2023-12-22 | PXD047650 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data